Search alternatives:
teer decrease » greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
10981
-
10982
-
10983
-
10984
-
10985
-
10986
-
10987
-
10988
-
10989
-
10990
CD45 and F-actin immunolocalization in the TM wholemounts.
Published 2014“…A2–E2: Inflammatory cells positive to CD45 (red) appear at 24 hrs after laser (B2) and decrease thereafter. …”
-
10991
-
10992
mRNA levels of CASP family markers (A-E), BCL2 family markers (F-H) and other apoptosis-related markers (I-M) in limbal stromal cells (LSCs) and in Aniridia-LSCs (AN-LSCs), after t...
Published 2025“…<p><i>CASP3, CASP7, CASP8, CASP9</i> and <i>CASP10</i> mRNA levels (A-E), <i>BCL2, BAX</i> and <i>BID</i> mRNA levels (F-H) and <i>CDKN1A, CDKN1B, TNFα, XIAP</i> and <i>BIRC5</i> mRNA levels (I-M) are shown. Values are expressed on a logarithmic scale (Log 2) with geometric mean±geometric standard deviation. …”
-
10993
Comparison of the amount of locomotor activity (mean counts per day) and the night-day ratio in control and diabetic animals submitted to two light schedules.
Published 2014“…(B) In the second light schedule, animals were submitted to successive decreases in light intensity. These SZT-diabetic mice exhibited a reduction in their total locomotor activity at the three light intensities (at 1000 lux: controls: 2099.5±122.1 counts; STZ-diabetic: 1704.7±125.9 counts; p≤0.01; at 300 lux: controls: 2658.7±112.9 counts; STZ-diabetic: 2124.4±0.1 counts; p≤0.001 and at 100 lux: controls: 2864.7±58.4 counts; STZ-diabetic: 2508.7±47.5 counts; p≤0.05), with a significant decreased ratio of night-day activity at 300 lux and 100 lux. …”
-
10994
-
10995
Analgesic prescriptions received by patients before commencing the BOA model of care for osteoarthritis: a Swedish national registry study with matched reference and clinical guide...
Published 2021“…Since guideline publication, the proportion of the OA cohort having no dispensed prescription analgesics prior to non-pharmacological primary care intervention concordantly increased by 5.0% (95% CI 4.2–5.9). Furthermore, dispensed prescriptions concordantly decreased for non-selective NSAIDs –8.6% (CI –9.6 to –7.6), weak opioids –6.8% (CI –7.7 to –5.9), glucosamine –9.5% (CI –9.8 to –8.8). and hyaluronic acid –1.6% (CI –1.8 to –1.5) but discordantly increased for strong opioids 2.8% (CI 2.1–3.4) and glucocorticoid intra-articular injection for hip OA 2.1% (CI 1.0–3.1).…”
-
10996
-
10997
-
10998
-
10999
-
11000